In summary, SKA3 is highly expressed in liver cancer and can alleviate the apoptosis of liver cancer cells, while promoting proliferation, which may be related to inhabiting the phosphorylation of p53 by interaction with CDK2 (Fig. 8). Here, CDK2 is linked to liver cancer.